Park Square Financial Group, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 2058285
ROSWELL, GA
Position in REGN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$1,247
-$2,612 QoQ
Shares Held
2
-60.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,307
of 1,322 holders
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Park Square Financial Group, LLC holds $11,999 across 3 Biotechnology names. REGN ranks #3 (10.4% of the industry book) .
All Filings in REGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,247 | 2 | Shares | Sole | 2026-07-31 | |
| 2025-12-31 | $3,859 | 5 | Shares | Sole | 2026-02-05 | |
| 2025-06-30 | $97,125 | 185 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $181,389 | 286 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $55,560 | 78 | Shares | Sole | 2025-02-28 | |
| No filing history on record for this holder in this stock. | ||||||